US Medical Director, Respiratory LCM (Non-Alliance)

Sanofi•Cambridge, MA

9d•$178,500 - $257,833•Onsite

About The Position

Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs. We are seeking a dynamic and experienced US Medical Director to lead the medical strategy for our Pulmonary and Allergy pipeline, including COPD, CRSwNP, among other obstructive airway disease. This is a high-impact role at the intersection of science, strategy, and patient care — ideal for a medical affairs leader with a strong US pre-launch and launch background, particularly in respiratory.

Requirements

Clinical or scientific designation required: MD, PhD, PharmD, NP/PA
Minimum 5 years of pharmaceutical experience within a Medical Affairs or R&D organization
Demonstrated expertise in US Medical Affairs Launch and Life Cycle Management in Respiratory
Experience in Respiratory and Allergy/Immunology strongly preferred
US launch experience in COPD and other obstructive airway disease — including pre-launch planning, launch execution, and post-launch LCM activities
Strong track record in developing and executing medical strategies in the US market
Experience in leveraging AI, LLM into medical strategy and execution
Scientific Acumen: Deep understanding of the scientific method; ability to translate data into medical and commercial relevant insights
Strategic Thinking: Ability to challenge the status quo with innovation while remaining pragmatic and priority-focused; translates strategy into actionable plans
Stakeholder Influence: Politically astute with strong cross-functional collaboration skills; effective at managing internal and external relationships
Results Orientation: Driven to deliver optimal outcomes aligned with corporate objectives; comfortable with ambiguity, agile, and proactive in risk management
Medical Affairs Expertise: Comprehensive knowledge of medical affairs strategies, clinical development, and regulatory/compliance frameworks

Nice To Haves

Preferred: US launch experience in COPD and other obstructive airway disease — including pre-launch planning, launch execution, and post-launch LCM activities

Responsibilities

Develop and execute integrated Pulmonary and Allergy medical plans encompassing Medical Science Liaisons, Medical Education, Medical Communications & Publications, Health Outcomes, Safety, Clinical Research (Phase IIIB–IV and Investigator Sponsored Trials) and RWE generation
Own the annual medical budget for assigned respiratory assets.
Lead Pulmonary and Allergy strategy to maximize the scientific and clinical value of the portfolio across all stages
Serve as the primary medical expert and strategic partner to clinical, commercial, market Access, and regulatory teams
Lead medical and scientific advisory board discussions to identify and elevate medically focused opportunities and strategic priorities within Respiratory and allergy
Provide disease state and product training to internal and external stakeholders
Build and maintain strong professional relationships with KOLs including healthcare practitioners and researchers — within the respiratory and allergy medical community
Identify and co-create research collaboration opportunities to address critical questions in patient care delivery
Provide medical review and approval of promotional and medical materials in full compliance with corporate standards and applicable government/industry regulations
Support the execution of US Phase IIIB–IV clinical study programs and lead the RWE plan and execution within LCM disease areas.
Review Investigator Sponsored Study (ISS) concepts and protocols per applicable SOPs
Partner with US Drug Safety in managing clinical trial adverse events, post-marketing safety data, and communication of identified safety signals